RHHBY

Roche (QX) News

Best deals to access real time data!
Small Cap Basic
Monthly Subscription
for only
$33.03
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
DDE w/Realtime (Monthly)
Monthly Subscription
for only
$34.10
VAT not included
Company Name Stock Ticker Symbol Market Type
Roche Holdings Ltd AG (QX) RHHBY OTCMarkets Depository Receipt
  Price Change Change Percent Stock Price Last Traded
0.91 1.83% 50.68 17:20:00
Open Price Low Price High Price Close Price Prev Close
50.67 50.32 50.83 50.68 49.77
more quote information »

Recent News

Date Time Source Heading
12/08/202111:11IHNWFeaturedCybin Confirms Scientific Advice Meeting with UK Medical and Healthcare Products Regulatory Agency for Lead Candidate CYB003 for the Treatment of Major Depressive Disorder and Alcohol Use Disorder
12/08/20219:37IHNWFeaturedHealixa Appoints Rep. Denver Riggleman to the Board of Directors
12/08/20218:34IHNWFeaturedMax Resource Identifies 5 Drill Target Zones and Reports New Assay Results from DT-3 at URU, CESAR Project, NE Colombia
12/08/20218:00IHNWFeaturedInnerScope Hearing Technologies (OTC: INND) Receives Walmart Purchase Orders of $277,000+ for In-Store Product Sales
12/07/202118:23SEEKRoche/Genentech spinal muscular atrophy treatment granted..
12/07/202113:04SEEKRoche COVID antibody treatment tocilizumab approved by EMA
12/07/202108:52DJNRecursion Pharmaceuticals Sets Drug-Discovery Pact With..
12/07/202108:09SEEKRecursion gains 9% on collaboration with Roche in..
12/07/202104:51DJNEU Approves Roche's Actemra/RoActemra Against Severe..
12/06/202113:17SEEKRoche's tocilizumab recommended for severe COVID by EMA..
12/03/202112:21DJNRoche to Name New Member to Board of Directors, Re-Elect..
12/03/202103:49SEEKRoche develops new research test kits for detection of..
11/22/202116:30SEEKGenentech's obinutuzumab granted Orphan Drug Designation for..
11/19/202109:46SEEKEuropean Commission approves Roche’s Gavreto for RET..
11/17/202110:26DJNAtea Pharma Shares Drop 16% After Collaboration With Roche..
11/11/202111:57DJNRegeneron Gets CHMP Backing for Covid-19 Cocktail
11/11/202111:43DJNEuropean Medicines Agency Recommends Ronapreve, Regkirona..
11/10/202111:57SEEKAC Immune falls 9% following phase 2 data on Alzheimer's..
11/10/202108:46SEEKRoche indicates its Alzheimer's drug would be priced below..
11/09/202111:25SEEKRegeneron, Roche COVID-19 cocktail likely to win EU ok this..
11/04/202103:03DJNNovartis to Sell Roche Stake to Roche for $20.7 Billion
10/20/202110:35SEEKAtea Pharmaceuticals continues to fall following..
10/20/202101:51DJNRoche 3Q Sales Grew; Raises Outlook
10/19/202108:56DJNAtea Shares Fall 75% After Covid-19 Trial Misses Objective
10/19/202108:06DJNAtea's Covid-19 Trial Misses Objective in Overall Patient..
10/19/202107:26SEEKAtea Pharmaceuticals' mid-stage AT-527 COVID-19 trial fails..
10/18/202117:14SEEKCelcuity to conduct study with Puma in breast cancer with..
10/18/202111:05SEEKPTC Therapeutics hits 52-week low following BofA downgrade
10/15/202113:20DJNGenentech: FDA Approves Tecentriq as Adjuvant Treatment for..
10/12/202113:23SEEKSanofi expects constraints for Kevzara supplies until early..
10/12/202108:45NNWReal-World Data, Point-of-Care Testing Reshaping Healthcare,..
10/12/202107:23DJNCombiGene Shares More Than Double on $328.5 Million Epilepsy..
10/08/202112:31DJNRoche's Gantenerumab Gets FDA Breakthrough Therapy..
10/07/202116:31SEEKMid-stage data from two cancer candidate disappoints;..
10/04/202109:00SEEKSurface Oncology plans to initiate mid-stage SRF388..
10/01/202113:18SEEKFDA accepts Coherus BioSciences' BLA filing for Lucentis..
9/30/202101:52DJNRoche: Phase 2/3 Trial of Covid-19 Treatment Ronapreve Met..
9/20/202108:21DJNBiogen, Samsung Bioepis Get FDA OK for Lucentis Biosimilar
9/20/202107:56SEEKFDA approves Samsung Bioepis and Biogen’s Byooviz
9/15/202108:00SEEKBiogen to start spinal muscular atrophy trial for higher..
9/09/202101:54DJNRoche to Acquire Biotech Company TIB Molbiol Group
9/07/202113:32DJNAdaptimmune Therapeutics Shares Rise 24% After Genentech..
9/07/202108:16DJNAdaptimmune Therapeutics in Licensing Deal With Genentech
9/01/202109:30TRMNAC Immune Jumps 16.3% on Partial Success in Alzheimer’s Drug..
8/31/202110:55DJNAC Immune Shares Rally on Renewed Hope for Semorinemab in..
8/31/202108:33DJNAC Immune: Semorinemab Meets Co-Primary Endpoint in..
8/27/202112:35DJNRoche Withdraws Accelerated Approval for Tecentriq Cancer..
8/09/202107:54SEEKGenentech's Polivy meets primary endpoint as first-line..
8/09/202102:58DJNRoche's Phase 3 Study on Polivy With Chemotherapy Regimen..
8/05/202113:22DJNSyros Pharmaceuticals Shares Rise After Supply Agreement..
8/05/202107:57DJNSyros Pharmaceuticals in Clinical Supply Agreement With..
8/03/202105:11SEEKFDA grants priority review to Genentech’s Tecentriq in lung..
7/22/202107:13SEEKRoche tops H1 consensus; Analysts expect drop in..
7/22/202105:26SEEKRoche to discuss Alzheimer's candidate with FDA
See more news about this stock »


Your Recent History
USOTC
RHHBY
Roche (QX)
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.